Bloomberg reported on Thursday 30 April 2026 that the revamped Chips Act II, slated for Commission adoption on 27 May, will grant the European Commission direct equity-stake authority in semiconductor fabrication plants 1. The instrument removes the member-state intermediary required under the original 2023 EU Chips Act, under which Berlin and Paris had to clear state-aid mechanisms before EU capital reached a fab.
Intel's cancellation of the €30bn Magdeburg project in early 2026 and GlobalFoundries' suspension of the €7.5bn Crolles fab together stripped €37.5bn from Chips Act I delivery, exposing the failure mode the new authority is built to fix. Both files relied on member-state aid mechanisms that took years to clear and proved insufficient to trigger private commitment when Intel posted a quarterly net loss and GlobalFoundries cited insufficient state-aid availability. By taking equity stakes directly, Brussels skips the bottleneck that delayed both files.
Operator demand remains the constraint the new instrument does not address. Magdeburg was cancelled because Intel pulled back globally; Crolles was suspended because GlobalFoundries judged the customer commitment thin. Direct-investment capital does not produce demand for chips that the operators in question were unwilling to underwrite. Italy's €211m photonic-chips state aid in April, routed through the Commission rather than Rome, is the template for what Commission-routed capital looks like in practice: small, surgical, application-specific, at the trailing edge rather than leading-edge logic. The first Chips Act II deployment after 27 May will signal whether Brussels intends to use the instrument at scale or as a backstop.
